SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-4760-14T1 A-0164-15T1 IN RE: ACCUTANE LITIGATION
The New Jersey Supreme Court Has Adopted the Expert Admissibility FACTORS AND Gatekeeping Function of the Trial Court's Enunciat
2020 Thomson Reuters. No claim to original U.S. Government Works. 1 235 N.J. 229 Supreme Court of New Jersey. IN RE: ACCUTANE
![New Jersey Appellate Panel Reverses Trial Court's Detailed Exclusion of Unreliable Expert Testimony - Life Science Matters New Jersey Appellate Panel Reverses Trial Court's Detailed Exclusion of Unreliable Expert Testimony - Life Science Matters](https://druganddeviceblog.com/wp-content/uploads/2020/12/Testify-87332375-ACT.png)
New Jersey Appellate Panel Reverses Trial Court's Detailed Exclusion of Unreliable Expert Testimony - Life Science Matters
NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A
![$25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice, Limitations - Litigation Blog - Litigation - LexisNexis® Legal Newsroom $25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice, Limitations - Litigation Blog - Litigation - LexisNexis® Legal Newsroom](https://www.lexisnexis.com/legalnewsroom/resized-image.ashx/__size/550x0/__key/telligent-evolution-components-attachments/13-07-00-00-00-00-13-20/ContentImage_2D00_Drugs2.jpg)
$25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice, Limitations - Litigation Blog - Litigation - LexisNexis® Legal Newsroom
![NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this Time Regarding Choice-of-Law and the Presumption of Adequacy for FDA-Approved Warnings | McCarter & English, LLP NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this Time Regarding Choice-of-Law and the Presumption of Adequacy for FDA-Approved Warnings | McCarter & English, LLP](https://2yrr8n1h5wj043subb2ardvg-wpengine.netdna-ssl.com/wp-content/uploads/2019/11/Insights-Publication-MagazineOpenStack.png)
NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this Time Regarding Choice-of-Law and the Presumption of Adequacy for FDA-Approved Warnings | McCarter & English, LLP
![New Addition to New Jersey Court Rules Impacts More Than Trial Practice - Lewis Brisbois Bisgaard & Smith LLP New Addition to New Jersey Court Rules Impacts More Than Trial Practice - Lewis Brisbois Bisgaard & Smith LLP](https://lewisbrisbois.com/assets/images/Wood_Gavel_NJ_flag.jpg)
New Addition to New Jersey Court Rules Impacts More Than Trial Practice - Lewis Brisbois Bisgaard & Smith LLP
![Johnson & Johnson Cites NJ Supreme Court's Accutane Decision in Talc Appeal | New Jersey Law Journal Johnson & Johnson Cites NJ Supreme Court's Accutane Decision in Talc Appeal | New Jersey Law Journal](https://images.law.com/contrib/content/uploads/sites/399/2018/08/Judge-Nelson-Johnson-Article-201808142111.jpg)
Johnson & Johnson Cites NJ Supreme Court's Accutane Decision in Talc Appeal | New Jersey Law Journal
![Another Expert Exclusion Order Secured by Colleen Hennessey and Team in New Jersey Accutane-IBD Litigation is Affirmed by the New Jersey Appellate Division – Peabody & Arnold Another Expert Exclusion Order Secured by Colleen Hennessey and Team in New Jersey Accutane-IBD Litigation is Affirmed by the New Jersey Appellate Division – Peabody & Arnold](https://www.peabodyarnold.com/wp-content/uploads/2017/03/News-Cases1-1442x470.jpg)